Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 22Thoracic 2Head & Neck 2Genitourinary 2Breast 2Sarcoma 1Other solid neoplasm 1Gynecologic 1Dermatologic 1

Conditions

Melanoma 28Carcinoma, Non-Small-Cell Lung 8Triple Negative Breast Neoplasms 6Carcinoma, Renal Cell 4Pancreatic Neoplasms 3Neoplasm Metastasis 3Skin Neoplasms 2Sarcoma 2Mesothelioma 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Squamous Cell Carcinoma of Head and Neck 1Spinocerebellar Degenerations 1Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 19Nivolumab 16Cyclophosphamide 9Specimen Handling 7Ipilimumab 7atezolizumab 6fludarabine 5Magnetic Resonance Spectroscopy 5durvalumab 3avelumab 3X-Rays 3Biopsy 3ulixertinib 2sargramostim 2poly ICLC 2lenvatinib 2epacadostat 2enzalutamide 2cemiplimab 2cabozantinib 2budigalimab 2aldesleukin 2Trastuzumab 2Sirolimus 2Paclitaxel 2Melphalan 2Interleukin-2 2Immunoglobulin G 2Immune Checkpoint Inhibitors 2Docetaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × spartalizumab × Dermatologic × Clear all
NCT04802876 2025-03-21

ACROPOLI

SOLTI Breast Cancer Research Group

Phase 2 Active not recruiting
184 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Uveal Melanoma, Anus Neoplasms, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Neoplasms, Unknown Primary, Sarcoma, Thyroid Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡